BRZE Braze | $43.99 -13.0% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $75.00 | N/A | View details for Oppenheimer rating of Braze (NASDAQ:BRZE) on 3/28/2024 |
CLRB Cellectar Biosciences | $3.95 +8.5% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $12.00 | N/A | View details for Oppenheimer rating of Cellectar Biosciences (NASDAQ:CLRB) on 3/28/2024 |
POOL Pool | $403.48 -2.7% | 3/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $407.00 -> $436.00 | N/A | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 3/28/2024 |
RUM Rumble | $8.28 -2.6% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Rumble (NASDAQ:RUM) on 3/28/2024 |
SPXC SPX Technologies | $122.04 +0.5% | 3/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $124.00 -> $134.00 | N/A | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 3/28/2024 |
CXM Sprinklr | $12.48 -4.1% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Sprinklr (NYSE:CXM) on 3/28/2024 |
|
VRNT Verint Systems | $33.14 +6.6% | 3/28/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Verint Systems (NASDAQ:VRNT) on 3/28/2024 |
IMVT Immunovant | $32.00 -1.6% | 3/28/2024 | Initiated by | Oppenheimer | - | Outperform | $50.00 | N/A | View details for Oppenheimer rating of Immunovant (NASDAQ:IMVT) on 3/28/2024 |
XERS Xeris Biopharma | $2.20 +7.8% | 3/28/2024 | Initiated by | Oppenheimer | - | Outperform | $5.00 | N/A | View details for Oppenheimer rating of Xeris Biopharma (NASDAQ:XERS) on 3/28/2024 |
CPRX Catalyst Pharmaceuticals | $15.88 -2.4% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $29.00 | Low | View details for Oppenheimer rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/27/2024 |
CGTX Cognition Therapeutics | $1.80 -1.0% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Cognition Therapeutics (NASDAQ:CGTX) on 3/27/2024 |
FRGE Forge Global | $1.94 -6.7% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $3.50 | Low | View details for Oppenheimer rating of Forge Global (NYSE:FRGE) on 3/27/2024 |
PRGS Progress Software | $52.70 +0.1% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $66.00 | Low | View details for Oppenheimer rating of Progress Software (NASDAQ:PRGS) on 3/27/2024 |
STRO Sutro Biopharma | $5.92 +20.1% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $10.00 | Low | View details for Oppenheimer rating of Sutro Biopharma (NASDAQ:STRO) on 3/27/2024 |
WPRT Westport Fuel Systems | $6.65 -2.2% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $19.00 | Low | View details for Oppenheimer rating of Westport Fuel Systems (NASDAQ:WPRT) on 3/27/2024 |
ADBE Adobe | $503.86 -0.1% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $660.00 | Low | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/27/2024 |
UPS United Parcel Service | $148.42 +0.7% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $153.00 | Low | View details for Oppenheimer rating of United Parcel Service (NYSE:UPS) on 3/27/2024 |
HCI HCI Group | $115.29 -0.2% | 3/27/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $140.00 | Low | View details for Oppenheimer rating of HCI Group (NYSE:HCI) on 3/27/2024 |
VKTX Viking Therapeutics | $82.10 -1.5% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $116.00 -> $138.00 | Low | View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024 |
ALSN Allison Transmission | $81.11 +0.4% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $90.00 | Low | View details for Oppenheimer rating of Allison Transmission (NYSE:ALSN) on 3/26/2024 |
A Agilent Technologies | $146.73 -0.4% | 3/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $67.00 -> $90.00 | Low | View details for Oppenheimer rating of Agilent Technologies (NYSE:A) on 3/26/2024 |
HARP Harpoon Therapeutics | $23.01 +0.1% | 3/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | N/A | View details for Oppenheimer rating of Harpoon Therapeutics (NASDAQ:HARP) on 3/26/2024 |
ADUS Addus HomeCare | $103.70 0.0% | 3/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $118.00 | Low | View details for Oppenheimer rating of Addus HomeCare (NASDAQ:ADUS) on 3/26/2024 |
DYN Dyne Therapeutics | $28.44 -0.2% | 3/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $47.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 3/26/2024 |
TH Target Hospitality | $10.95 -0.1% | 3/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $10.00 | Low | View details for Oppenheimer rating of Target Hospitality (NASDAQ:TH) on 3/25/2024 |
TSLA Tesla | $176.90 -1.6% | 3/25/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 3/25/2024 |
AMPX Amprius Technologies | $2.72 +3.0% | 3/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 | Low | View details for Oppenheimer rating of Amprius Technologies (NYSE:AMPX) on 3/22/2024 |
DRI Darden Restaurants | $167.32 +0.2% | 3/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $186.00 -> $182.00 | Low | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/22/2024 |
FDS FactSet Research Systems | $450.99 +0.8% | 3/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of FactSet Research Systems (NYSE:FDS) on 3/22/2024 |
FDX FedEx | $289.16 +0.4% | 3/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of FedEx (NYSE:FDX) on 3/22/2024 |
SHAK Shake Shack | $104.99 +0.7% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $108.00 -> $120.00 | Low | View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 3/22/2024 |
ROP Roper Technologies | $558.51 -0.1% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $580.00 -> $650.00 | Low | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 3/22/2024 |
KNF Knife River | $81.21 +1.4% | 3/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $75.00 -> $85.00 | Low | View details for Oppenheimer rating of Knife River (NYSE:KNF) on 3/22/2024 |
DMAC DiaMedica Therapeutics | $2.75 +3.8% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $6.00 | Low | View details for Oppenheimer rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 3/21/2024 |
TKR Timken | $87.45 -0.8% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $100.00 | Low | View details for Oppenheimer rating of Timken (NYSE:TKR) on 3/21/2024 |
TOL Toll Brothers | $129.24 +1.4% | 3/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $141.00 -> $157.00 | Low | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 3/21/2024 |
TRVI Trevi Therapeutics | $3.45 -0.6% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $9.00 | Low | View details for Oppenheimer rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/21/2024 |
VOR Vor Biopharma | $2.32 +5.0% | 3/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $15.00 | Low | View details for Oppenheimer rating of Vor Biopharma (NYSE:VOR) on 3/21/2024 |
DKS DICK'S Sporting Goods | $223.06 +0.2% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $240.00 | Low | View details for Oppenheimer rating of DICK’S Sporting Goods (NYSE:DKS) on 3/20/2024 |
CSL Carlisle Companies | $391.67 +0.8% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $355.00 -> $405.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 3/20/2024 |
AI to Meet the Same Fate as EVs? (Ad) When these tech bubbles burst, they invariably leave investors disillusioned by their losses.
Now, many worry a similar fate is awaiting AI.
And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. |
CRNX Crinetics Pharmaceuticals | $46.87 +5.5% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $55.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/20/2024 |
EQIX Equinix | $823.23 +1.0% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $875.00 -> $950.00 | Low | View details for Oppenheimer rating of Equinix (NASDAQ:EQIX) on 3/20/2024 |
NVDA NVIDIA | $904.14 +0.2% | 3/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $850.00 -> $1,100.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 3/20/2024 |
CRVS Corvus Pharmaceuticals | $1.80 +0.6% | 3/20/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $8.00 -> $7.00 | Low | View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 3/20/2024 |
STEP StepStone Group | $35.05 -0.1% | 3/20/2024 | Initiated by | Oppenheimer | - | Outperform | $48.00 | Low | View details for Oppenheimer rating of StepStone Group (NASDAQ:STEP) on 3/20/2024 |
GRWG GrowGeneration | $2.90 -4.9% | 3/20/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of GrowGeneration (NASDAQ:GRWG) on 3/20/2024 |
C Citigroup | $63.20 +0.7% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $88.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 3/19/2024 |
CATX Perspective Therapeutics | 1.19 -0.8% | 3/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | 1.20 | N/A | View details for Oppenheimer rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 3/19/2024 |
GS The Goldman Sachs Group | $416.63 +0.3% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $506.00 -> $446.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 3/19/2024 |
JPM JPMorgan Chase & Co. | $200.13 +0.3% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $238.00 -> $219.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 3/19/2024 |
MS Morgan Stanley | $94.19 +0.7% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $109.00 -> $97.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 3/19/2024 |
USB U.S. Bancorp | $44.81 +1.8% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $61.00 -> $55.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 3/19/2024 |
WFC Wells Fargo & Company | $58.00 +0.7% | 3/19/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Wells Fargo & Company (NYSE:WFC) on 3/19/2024 |
ALPN Alpine Immune Sciences | $38.51 -0.4% | 3/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $33.00 -> $44.00 | Low | View details for Oppenheimer rating of Alpine Immune Sciences (NASDAQ:ALPN) on 3/19/2024 |
BAC Bank of America | $37.85 +0.1% | 3/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $46.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 3/19/2024 |
MOD Modine Manufacturing | $94.75 -0.5% | 3/19/2024 | Initiated by | Oppenheimer | - | Outperform | $105.00 | Low | View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 3/19/2024 |
CRBP Corbus Pharmaceuticals | $39.44 +10.9% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $51.00 -> $58.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 3/13/2024 |
CRNX Crinetics Pharmaceuticals | $46.87 +5.5% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $54.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/13/2024 |
DRI Darden Restaurants | $167.32 +0.2% | 3/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $186.00 | Low | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/13/2024 |
RRX Regal Rexnord | $179.06 +0.4% | 3/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $210.00 | Low | View details for Oppenheimer rating of Regal Rexnord (NYSE:RRX) on 3/13/2024 |
TRMB Trimble | $64.19 +1.4% | 3/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $72.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 3/14/2024 |
ADBE Adobe | $503.86 -0.1% | 3/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $660.00 | N/A | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/15/2024 |
LEN Lennar | $171.30 +1.7% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Lennar (NYSE:LEN) on 3/15/2024 |
MDGL Madrigal Pharmaceuticals | $264.37 +2.1% | 3/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $320.00 -> $375.00 | N/A | View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/15/2024 |
PTMN Portman Ridge Finance | $18.84 +0.7% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $20.00 | N/A | View details for Oppenheimer rating of Portman Ridge Finance (NASDAQ:PTMN) on 3/15/2024 |
SEIC SEI Investments | $71.85 -0.2% | 3/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $73.00 -> $77.00 | N/A | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 3/15/2024 |
SMAR Smartsheet | $38.33 -0.2% | 3/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $55.00 | N/A | View details for Oppenheimer rating of Smartsheet (NYSE:SMAR) on 3/15/2024 |
URGN UroGen Pharma | $14.92 -0.3% | 3/15/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $35.00 -> $34.00 | N/A | View details for Oppenheimer rating of UroGen Pharma (NASDAQ:URGN) on 3/15/2024 |
WSM Williams-Sonoma | $316.80 +0.9% | 3/15/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | N/A | View details for Oppenheimer rating of Williams-Sonoma (NYSE:WSM) on 3/15/2024 |
EW Edwards Lifesciences | $95.33 +0.2% | 3/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $93.00 -> $100.00 | Low | View details for Oppenheimer rating of Edwards Lifesciences (NYSE:EW) on 3/18/2024 |
WCN Waste Connections | $171.70 +0.0% | 3/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $170.00 -> $180.00 | Low | View details for Oppenheimer rating of Waste Connections (NYSE:WCN) on 3/18/2024 |
VTYX Ventyx Biosciences | $5.57 -4.1% | 3/12/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $12.00 | Low | View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 3/12/2024 |
NFLX Netflix | $605.49 -1.3% | 3/11/2024 | Target Raised by | Oppenheimer | - | Outperform | $615.00 -> $725.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 3/11/2024 |
RWAY Runway Growth Finance | $12.17 +0.4% | 3/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Runway Growth Finance (NASDAQ:RWAY) on 3/8/2024 |
FIGS FIGS | $4.95 -0.4% | 3/8/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of FIGS (NYSE:FIGS) on 3/8/2024 |
FROG JFrog | $44.08 +0.4% | 3/7/2024 | Target Raised by | Oppenheimer | - | | $41.00 -> $48.00 | Low | View details for Oppenheimer rating of JFrog (NASDAQ:FROG) on 3/7/2024 |
EHAB Enhabit | $11.66 +0.9% | 3/7/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Enhabit (NYSE:EHAB) on 3/7/2024 |
JSPR Jasper Therapeutics | $29.85 +3.6% | 3/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $80.00 | Low | View details for Oppenheimer rating of Jasper Therapeutics (NASDAQ:JSPR) on 3/7/2024 |
MRNS Marinus Pharmaceuticals | $9.05 +2.3% | 3/7/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $9.00 | Low | View details for Oppenheimer rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 3/7/2024 |
PNR Pentair | $85.03 +0.0% | 3/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $82.00 -> $88.00 | Low | View details for Oppenheimer rating of Pentair (NYSE:PNR) on 3/7/2024 |
RSI Rush Street Interactive | $6.49 +0.5% | 3/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $9.00 | Low | View details for Oppenheimer rating of Rush Street Interactive (NYSE:RSI) on 3/7/2024 |
WCC WESCO International | $171.39 +0.3% | 3/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $190.00 | N/A | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 3/7/2024 |
AOMR Angel Oak Mortgage REIT | $10.97
| 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Angel Oak Mortgage REIT (NYSE:AOMR) on 3/6/2024 |
CNNE Cannae | $22.29 -0.7% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $27.00 | Low | View details for Oppenheimer rating of Cannae (NYSE:CNNE) on 3/6/2024 |
CHPT ChargePoint | $1.93 +1.3% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of ChargePoint (NYSE:CHPT) on 3/6/2024 |
BASE Couchbase | $26.46 +1.3% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $36.00 | Low | View details for Oppenheimer rating of Couchbase (NASDAQ:BASE) on 3/6/2024 |
CRWD CrowdStrike | $321.30 -0.3% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $355.00 | N/A | View details for Oppenheimer rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
DG Dollar General | $155.68 +1.0% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Dollar General (NYSE:DG) on 3/6/2024 |
HCP HashiCorp | $27.15 +0.6% | 3/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $34.00 | Low | View details for Oppenheimer rating of HashiCorp (NASDAQ:HCP) on 3/6/2024 |
IONS Ionis Pharmaceuticals | $43.63 -2.3% | 3/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $72.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 3/6/2024 |
AI to Meet the Same Fate as EVs? (Ad) When these tech bubbles burst, they invariably leave investors disillusioned by their losses.
Now, many worry a similar fate is awaiting AI.
And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. |
MCRB Seres Therapeutics | $0.78 -0.1% | 3/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $9.00 -> $5.00 | Low | View details for Oppenheimer rating of Seres Therapeutics (NASDAQ:MCRB) on 3/6/2024 |
SCM Stellus Capital Investment | $13.12 -0.2% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $14.00 | Low | View details for Oppenheimer rating of Stellus Capital Investment (NYSE:SCM) on 3/6/2024 |
SYF Synchrony Financial | $43.09 +1.9% | 3/6/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Synchrony Financial (NYSE:SYF) on 3/6/2024 |
AEVA Aeva Technologies | $3.96 +11.9% | 3/6/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Aeva Technologies (NYSE:AEVA) on 3/6/2024 |
ETNB 89bio | $11.58 +2.4% | 3/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of 89bio (NASDAQ:ETNB) on 3/5/2024 |
CODI Compass Diversified | $23.99 -0.2% | 3/5/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $21.00 -> $23.00 | Low | View details for Oppenheimer rating of Compass Diversified (NYSE:CODI) on 3/5/2024 |
COST Costco Wholesale | $729.92 -0.3% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $760.00 -> $805.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 3/5/2024 |
DYN Dyne Therapeutics | $28.44 -0.2% | 3/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $44.00 -> $47.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 3/5/2024 |
GE General Electric | $174.91 -2.9% | 3/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of General Electric (NYSE:GE) on 3/5/2024 |
IMRX Immuneering | $2.84 +16.9% | 3/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Immuneering (NASDAQ:IMRX) on 3/5/2024 |
GWW W.W. Grainger | $1,015.69 -0.4% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $1,075.00 -> $1,125.00 | Low | View details for Oppenheimer rating of W.W. Grainger (NYSE:GWW) on 3/5/2024 |
AVDL Avadel Pharmaceuticals | $16.82 -0.1% | 3/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $27.00 -> $29.00 | Low | View details for Oppenheimer rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 3/5/2024 |
DLTR Dollar Tree | $133.52 +0.8% | 3/4/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Dollar Tree (NASDAQ:DLTR) on 3/4/2024 |
CYTK Cytokinetics | $70.49 -1.3% | 3/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $107.00 | Low | View details for Oppenheimer rating of Cytokinetics (NASDAQ:CYTK) on 3/4/2024 |
LOW Lowe's Companies | $254.49 +0.5% | 3/4/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $230.00 | Low | View details for Oppenheimer rating of Lowe’s Companies (NYSE:LOW) on 3/4/2024 |
MDGL Madrigal Pharmaceuticals | $264.37 +2.1% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $320.00 | Low | View details for Oppenheimer rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/1/2024 |
SG Sweetgreen | $25.11 -1.5% | 3/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $17.00 | Low | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 3/1/2024 |
PNTG The Pennant Group | $19.76 -0.4% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $22.00 | Low | View details for Oppenheimer rating of The Pennant Group (NASDAQ:PNTG) on 3/1/2024 |
ADSK Autodesk | $260.65 -0.1% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $265.00 -> $315.00 | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 3/1/2024 |
AVGO Broadcom | $1,319.84 +0.1% | 3/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $1,100.00 -> $1,500.00 | Low | View details for Oppenheimer rating of Broadcom (NASDAQ:AVGO) on 3/1/2024 |
ESTC Elastic | $100.54 +0.4% | 3/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $130.00 | Low | View details for Oppenheimer rating of Elastic (NYSE:ESTC) on 3/1/2024 |
HRZN Horizon Technology Finance | $11.38 +1.2% | 3/1/2024 | Target Lowered by | Oppenheimer | - | Market Perform -> Market Perform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Horizon Technology Finance (NASDAQ:HRZN) on 3/1/2024 |
EVH Evolent Health | $33.10 +1.1% | 3/1/2024 | Initiated by | Oppenheimer | - | Outperform | $45.00 | N/A | View details for Oppenheimer rating of Evolent Health (NYSE:EVH) on 3/1/2024 |
TBLA Taboola.com | $4.47 +1.6% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $6.00 | Low | View details for Oppenheimer rating of Taboola.com (NASDAQ:TBLA) on 2/29/2024 |
CHE Chemed | $643.61 -0.1% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $625.00 -> $650.00 | Low | View details for Oppenheimer rating of Chemed (NYSE:CHE) on 2/29/2024 |
CRNX Crinetics Pharmaceuticals | $46.87 +5.5% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $48.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 2/29/2024 |
IMCR Immunocore | $64.12 +0.8% | 2/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $87.00 | Low | View details for Oppenheimer rating of Immunocore (NASDAQ:IMCR) on 2/29/2024 |
MRVL Marvell Technology | $70.96 -1.9% | 2/29/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $80.00 | Low | View details for Oppenheimer rating of Marvell Technology (NASDAQ:MRVL) on 2/29/2024 |
MMSI Merit Medical Systems | $75.99 +0.7% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $82.00 -> $87.00 | Low | View details for Oppenheimer rating of Merit Medical Systems (NASDAQ:MMSI) on 2/29/2024 |
OKTA Okta | $104.58 -0.3% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $125.00 | Low | View details for Oppenheimer rating of Okta (NASDAQ:OKTA) on 2/29/2024 |
RLJ RLJ Lodging Trust | $11.75 +0.1% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $15.00 | Low | View details for Oppenheimer rating of RLJ Lodging Trust (NYSE:RLJ) on 2/29/2024 |
RXST RxSight | $50.93 +0.5% | 2/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $61.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 2/29/2024 |
SHLS Shoals Technologies Group | $11.36 -3.4% | 2/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $42.00 -> $17.00 | Low | View details for Oppenheimer rating of Shoals Technologies Group (NASDAQ:SHLS) on 2/29/2024 |
SNOW Snowflake | $162.82 +1.7% | 2/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $240.00 -> $220.00 | Low | View details for Oppenheimer rating of Snowflake (NYSE:SNOW) on 2/29/2024 |
ARVN Arvinas | $41.28 -0.1% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $80.00 | Low | View details for Oppenheimer rating of Arvinas (NASDAQ:ARVN) on 2/28/2024 |
CLVT Clarivate | $7.46
| 2/28/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Clarivate (NYSE:CLVT) on 2/28/2024 |
COMP Compass | $3.60 +3.7% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $5.50 -> $6.00 | Low | View details for Oppenheimer rating of Compass (NYSE:COMP) on 2/28/2024 |
FSLR First Solar | $169.13 +1.0% | 2/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $268.00 -> $269.00 | Low | View details for Oppenheimer rating of First Solar (NASDAQ:FSLR) on 2/28/2024 |
IAS Integral Ad Science | $10.06 +7.0% | 2/28/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $20.00 | Low | View details for Oppenheimer rating of Integral Ad Science (NASDAQ:IAS) on 2/28/2024 |
QUIK QuickLogic | $16.13 +2.7% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $16.00 | Low | View details for Oppenheimer rating of QuickLogic (NASDAQ:QUIK) on 2/28/2024 |
RSG Republic Services | $191.49 0.0% | 2/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $182.00 -> $195.00 | Low | View details for Oppenheimer rating of Republic Services (NYSE:RSG) on 2/28/2024 |
TARS Tarsus Pharmaceuticals | $36.89 +6.7% | 2/28/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $59.00 | Low | View details for Oppenheimer rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 2/28/2024 |
VKTX Viking Therapeutics | $82.10 -1.5% | 2/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $46.00 -> $116.00 | Low | View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 2/28/2024 |
WMT Walmart | $60.44 -0.5% | 2/26/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $67.00 | Low | View details for Oppenheimer rating of Walmart (NYSE:WMT) on 2/26/2024 |
CARG CarGurus | $23.08 +0.3% | 2/27/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $26.00 -> $30.00 | Low | View details for Oppenheimer rating of CarGurus (NASDAQ:CARG) on 2/27/2024 |
DAWN Day One Biopharmaceuticals | $16.41 +3.9% | 2/27/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 2/27/2024 |
FATE Fate Therapeutics | $7.46 +1.6% | 2/27/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Fate Therapeutics (NASDAQ:FATE) on 2/27/2024 |
TMDX TransMedics Group | $74.88 +1.0% | 2/27/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $92.00 -> $105.00 | Low | View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 2/27/2024 |
IONS Ionis Pharmaceuticals | $43.63 -2.3% | 2/26/2024 | Reiterated by | Oppenheimer | - | Outperform | $63.00 -> $65.00 | Low | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 2/26/2024 |
MAIN Main Street Capital | $47.31 +1.1% | 2/26/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $41.00 -> $43.00 | Low | View details for Oppenheimer rating of Main Street Capital (NYSE:MAIN) on 2/26/2024 |
AI to Meet the Same Fate as EVs? (Ad) When these tech bubbles burst, they invariably leave investors disillusioned by their losses.
Now, many worry a similar fate is awaiting AI.
And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. |
POOL Pool | $403.48 -2.7% | 2/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $370.00 -> $407.00 | Low | View details for Oppenheimer rating of Pool (NASDAQ:POOL) on 2/26/2024 |
SONY Sony Group | $85.85 -0.8% | 2/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $108.00 | Low | View details for Oppenheimer rating of Sony Group (NYSE:SONY) on 2/26/2024 |
TGT Target | $176.15 +0.8% | 2/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $160.00 -> $170.00 | Low | View details for Oppenheimer rating of Target (NYSE:TGT) on 2/26/2024 |
NICE NICE | $261.75 +2.4% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $225.00 -> $300.00 | Low | View details for Oppenheimer rating of NICE (NASDAQ:NICE) on 2/23/2024 |
OLED Universal Display | $169.82 +1.2% | 2/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $210.00 -> $200.00 | Low | View details for Oppenheimer rating of Universal Display (NASDAQ:OLED) on 2/23/2024 |
SPXC SPX Technologies | $122.04 +0.5% | 2/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $118.00 -> $124.00 | Low | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 2/23/2024 |
TOL Toll Brothers | $129.24 +1.4% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $141.00 | Low | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 2/23/2024 |
ACA Arcosa | $85.34 -0.8% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $90.00 | Low | View details for Oppenheimer rating of Arcosa (NYSE:ACA) on 2/23/2024 |
ALTR Altair Engineering | $85.83 -0.5% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $100.00 | Low | View details for Oppenheimer rating of Altair Engineering (NASDAQ:ALTR) on 2/23/2024 |
BLDR Builders FirstSource | $208.96 -0.3% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $220.00 -> $242.00 | Low | View details for Oppenheimer rating of Builders FirstSource (NYSE:BLDR) on 2/23/2024 |
CCAP Crescent Capital BDC | $17.27 +1.4% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $19.00 | Low | View details for Oppenheimer rating of Crescent Capital BDC (NASDAQ:CCAP) on 2/23/2024 |
INTU Intuit | $648.73 0.0% | 2/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $678.00 -> $712.00 | Low | View details for Oppenheimer rating of Intuit (NASDAQ:INTU) on 2/23/2024 |
CYH Community Health Systems | $3.48 +2.4% | 2/22/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $6.50 -> $5.50 | Low | View details for Oppenheimer rating of Community Health Systems (NYSE:CYH) on 2/22/2024 |
DOCN DigitalOcean | $38.38 -1.8% | 2/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $37.00 -> $46.00 | Low | View details for Oppenheimer rating of DigitalOcean (NASDAQ:DOCN) on 2/22/2024 |
NVDA NVIDIA | $904.14 +0.2% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $850.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 2/22/2024 |
ADI Analog Devices | $196.92 +1.9% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $215.00 | Low | View details for Oppenheimer rating of Analog Devices (NASDAQ:ADI) on 2/22/2024 |
JACK Jack in the Box | $68.72 -2.5% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $98.00 | Low | View details for Oppenheimer rating of Jack in the Box (NASDAQ:JACK) on 2/22/2024 |
PNST Pinstripes | $3.27 -1.2% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $6.00 | Low | View details for Oppenheimer rating of Pinstripes (NYSE:PNST) on 2/22/2024 |
CAKE Cheesecake Factory | $36.29 -0.2% | 2/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Cheesecake Factory (NASDAQ:CAKE) on 2/22/2024 |
RUN Sunrun | $13.28 +1.4% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $19.00 | Low | View details for Oppenheimer rating of Sunrun (NASDAQ:RUN) on 2/22/2024 |
CNNE Cannae | $22.29 -0.7% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 | Low | View details for Oppenheimer rating of Cannae (NYSE:CNNE) on 2/22/2024 |
ADSK Autodesk | $260.65 -0.1% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $265.00 | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 2/22/2024 |
GWRE Guidewire Software | $116.08 +0.6% | 2/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $115.00 -> $130.00 | Low | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 2/22/2024 |
VEEV Veeva Systems | $232.41 -0.4% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $225.00 | Low | View details for Oppenheimer rating of Veeva Systems (NYSE:VEEV) on 2/22/2024 |
SKIL Skillsoft | $9.17 +2.7% | 2/22/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Skillsoft (NASDAQ:SKIL) on 2/22/2024 |
CLH Clean Harbors | $201.71 +0.6% | 2/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $178.00 -> $200.00 | Low | View details for Oppenheimer rating of Clean Harbors (NYSE:CLH) on 2/22/2024 |
DPZ Domino's Pizza | $494.61 +0.5% | 2/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $470.00 | Low | View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 2/22/2024 |
NVRO Nevro | $14.50 +0.6% | 2/22/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Nevro (NYSE:NVRO) on 2/22/2024 |
VTYX Ventyx Biosciences | $5.57 -4.1% | 2/21/2024 | Reiterated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Ventyx Biosciences (NASDAQ:VTYX) on 2/21/2024 |
LYV Live Nation Entertainment | $106.27 -0.5% | 2/21/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $105.00 -> $115.00 | Low | View details for Oppenheimer rating of Live Nation Entertainment (NYSE:LYV) on 2/21/2024 |
MDT Medtronic | $87.26 +0.4% | 2/21/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $89.00 -> $92.00 | Low | View details for Oppenheimer rating of Medtronic (NYSE:MDT) on 2/21/2024 |
PANW Palo Alto Networks | $283.26 +0.4% | 2/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $310.00 -> $305.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 2/21/2024 |
TPH Tri Pointe Homes | $38.45 +1.4% | 2/21/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $41.00 | Low | View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 2/21/2024 |
B Barnes Group | $37.16 -0.9% | 2/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $43.00 | Low | View details for Oppenheimer rating of Barnes Group (NYSE:B) on 2/20/2024 |
DKNG DraftKings | $45.37 +0.0% | 2/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $60.00 | Low | View details for Oppenheimer rating of DraftKings (NASDAQ:DKNG) on 2/20/2024 |
PRTA Prothena | $25.12 -0.2% | 2/20/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $98.00 -> $80.00 | Low | View details for Oppenheimer rating of Prothena (NASDAQ:PRTA) on 2/20/2024 |
ALB Albemarle | $131.26 +1.9% | 2/16/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $191.00 -> $188.00 | Low | View details for Oppenheimer rating of Albemarle (NYSE:ALB) on 2/16/2024 |
BLZE Backblaze | $10.23 +0.7% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $7.50 -> $11.00 | Low | View details for Oppenheimer rating of Backblaze (NASDAQ:BLZE) on 2/16/2024 |
COIN Coinbase Global | $266.86 +4.0% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $160.00 -> $200.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 2/16/2024 |
DASH DoorDash | $138.82 0.0% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $140.00 | Low | View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 2/16/2024 |
FRPT Freshpet | $115.69 0.0% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $115.00 | Low | View details for Oppenheimer rating of Freshpet (NASDAQ:FRPT) on 2/16/2024 |
NVDA NVIDIA | $904.14 +0.2% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $650.00 -> $850.00 | Low | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 2/16/2024 |
SCI Service Co. International | $74.19 0.0% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $71.00 -> $76.00 | Low | View details for Oppenheimer rating of Service Co. International (NYSE:SCI) on 2/16/2024 |
SHAK Shake Shack | $104.99 +0.7% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $80.00 -> $108.00 | Low | View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 2/16/2024 |
TTD Trade Desk | $87.95 +0.8% | 2/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $105.00 | Low | View details for Oppenheimer rating of Trade Desk (NASDAQ:TTD) on 2/16/2024 |
ROKU Roku | $65.30 -0.4% | 2/16/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Roku (NASDAQ:ROKU) on 2/16/2024 |
NKE NIKE | $93.86 -0.3% | 2/16/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | $110.00 | Low | View details for Oppenheimer rating of NIKE (NYSE:NKE) on 2/16/2024 |
BIIB Biogen | $215.34 -0.5% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $295.00 -> $290.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 2/14/2024 |
BOWL Bowlero | $13.60 +0.3% | 2/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $18.00 | Low | View details for Oppenheimer rating of Bowlero (NYSE:BOWL) on 2/14/2024 |
DENN Denny's | $8.99 -0.8% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $13.00 -> $12.00 | Low | View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 2/14/2024 |
AI to Meet the Same Fate as EVs? (Ad) When these tech bubbles burst, they invariably leave investors disillusioned by their losses.
Now, many worry a similar fate is awaiting AI.
And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. |
GCMG GCM Grosvenor | $9.50 +2.3% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $13.00 -> $12.00 | Low | View details for Oppenheimer rating of GCM Grosvenor (NASDAQ:GCMG) on 2/14/2024 |
MCO Moody's | $393.93 +0.9% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $427.00 -> $411.00 | Low | View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 2/14/2024 |
WCC WESCO International | $171.39 +0.3% | 2/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $175.00 | Low | View details for Oppenheimer rating of WESCO International (NYSE:WCC) on 2/14/2024 |
WM Waste Management | $212.42 -0.7% | 2/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $188.00 -> $212.00 | Low | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 2/14/2024 |
XPO XPO | $121.15 +0.2% | 2/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $130.00 | Low | View details for Oppenheimer rating of XPO (NYSE:XPO) on 2/14/2024 |
ANET Arista Networks | $289.91 +0.5% | 2/13/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Arista Networks (NYSE:ANET) on 2/13/2024 |
MNDY monday.com | $224.78 -0.9% | 2/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $220.00 -> $240.00 | Low | View details for Oppenheimer rating of monday.com (NASDAQ:MNDY) on 2/13/2024 |
RXO RXO | $22.08 +3.9% | 2/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $23.00 -> $22.00 | Low | View details for Oppenheimer rating of RXO (NYSE:RXO) on 2/13/2024 |
TRMB Trimble | $64.19 +1.4% | 2/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $59.00 -> $65.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 2/13/2024 |
DKNG DraftKings | $45.37 +0.0% | 2/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $44.00 -> $55.00 | Low | View details for Oppenheimer rating of DraftKings (NASDAQ:DKNG) on 2/13/2024 |
GILD Gilead Sciences | $73.48 +0.6% | 2/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $115.00 -> $105.00 | Low | View details for Oppenheimer rating of Gilead Sciences (NASDAQ:GILD) on 2/12/2024 |
CRM Salesforce | $300.77 -0.2% | 2/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $325.00 | Low | View details for Oppenheimer rating of Salesforce (NYSE:CRM) on 2/12/2024 |
WMT Walmart | $60.44 -0.5% | 2/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $58.33 -> $61.67 | Low | View details for Oppenheimer rating of Walmart (NYSE:WMT) on 2/12/2024 |
PSBD Palmer Square Capital BDC | $16.11 -2.1% | 2/12/2024 | Initiated by | Oppenheimer | - | Outperform | $17.00 | Low | View details for Oppenheimer rating of Palmer Square Capital BDC (NYSE:PSBD) on 2/12/2024 |
BILL BILL | $69.31 +2.5% | 2/9/2024 | Target Raised by | Oppenheimer | - | Overweight -> Overweight | $75.00 -> $83.00 | Low | View details for Oppenheimer rating of BILL (NYSE:BILL) on 2/9/2024 |
ENS EnerSys | $94.57 +0.4% | 2/9/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of EnerSys (NYSE:ENS) on 2/9/2024 |
FUN Cedar Fair | $41.49 +0.0% | 2/8/2024 | Initiated by | Oppenheimer | - | Outperform | $49.00 | Low | View details for Oppenheimer rating of Cedar Fair (NYSE:FUN) on 2/8/2024 |
ENPH Enphase Energy | $120.26 +0.4% | 2/7/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $133.00 | Low | View details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 2/7/2024 |
CHD Church & Dwight | $104.33 +0.1% | 2/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $107.00 -> $110.00 | Low | View details for Oppenheimer rating of Church & Dwight (NYSE:CHD) on 2/5/2024 |
EXPE Expedia Group | $138.49 -0.4% | 2/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $175.00 | Low | View details for Oppenheimer rating of Expedia Group (NASDAQ:EXPE) on 2/5/2024 |
WT WisdomTree | $9.17 +2.7% | 2/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $12.00 | Low | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 2/5/2024 |
ACAD ACADIA Pharmaceuticals | $18.35 +0.8% | 2/5/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | $25.00 | Low | View details for Oppenheimer rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 2/5/2024 |
BKNG Booking | $3,637.10 -1.0% | 2/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $3,450.00 -> $4,200.00 | Low | View details for Oppenheimer rating of Booking (NASDAQ:BKNG) on 2/5/2024 |
AAPL Apple | $171.57 -1.0% | 2/2/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $200.00 | Low | View details for Oppenheimer rating of Apple (NASDAQ:AAPL) on 2/2/2024 |
CTVA Corteva | $58.07 +1.9% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $62.00 | Low | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 2/2/2024 |
COST Costco Wholesale | $729.92 -0.3% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $695.00 -> $760.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 2/2/2024 |
DOV Dover | $177.28 +0.0% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $175.00 -> $177.00 | Low | View details for Oppenheimer rating of Dover (NYSE:DOV) on 2/2/2024 |
THG The Hanover Insurance Group | $136.30 +0.6% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $135.00 -> $150.00 | Low | View details for Oppenheimer rating of The Hanover Insurance Group (NYSE:THG) on 2/2/2024 |
MPWR Monolithic Power Systems | $673.59 +0.1% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $600.00 -> $700.00 | Low | View details for Oppenheimer rating of Monolithic Power Systems (NASDAQ:MPWR) on 2/2/2024 |
ENSG The Ensign Group | $124.88 -0.6% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $127.00 -> $130.00 | Low | View details for Oppenheimer rating of The Ensign Group (NASDAQ:ENSG) on 2/2/2024 |
META Meta Platforms | $488.14 -1.2% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $385.00 -> $525.00 | Low | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 2/2/2024 |
AMZN Amazon.com | $180.48 +0.4% | 2/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $210.00 | Low | View details for Oppenheimer rating of Amazon.com (NASDAQ:AMZN) on 2/2/2024 |
PTC PTC | $189.19 -0.3% | 2/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $210.00 | Low | View details for Oppenheimer rating of PTC (NASDAQ:PTC) on 2/1/2024 |
SEIC SEI Investments | $71.85 -0.2% | 2/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $71.00 -> $73.00 | Low | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 2/1/2024 |
ROP Roper Technologies | $558.51 -0.1% | 2/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $580.00 | Low | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 2/1/2024 |
NDAQ Nasdaq | $62.90 -0.2% | 2/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $68.00 | Low | View details for Oppenheimer rating of Nasdaq (NASDAQ:NDAQ) on 2/1/2024 |
NXPI NXP Semiconductors | $246.60 +0.5% | 2/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $220.00 -> $250.00 | Low | View details for Oppenheimer rating of NXP Semiconductors (NASDAQ:NXPI) on 2/1/2024 |
MA Mastercard | $480.34 +0.5% | 2/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $510.00 | Low | View details for Oppenheimer rating of Mastercard (NYSE:MA) on 2/1/2024 |
BSX Boston Scientific | $68.58 -0.1% | 2/1/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $58.00 -> $68.00 | Low | View details for Oppenheimer rating of Boston Scientific (NYSE:BSX) on 2/1/2024 |
APTV Aptiv | $78.98 +0.4% | 2/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $149.00 -> $148.00 | Low | View details for Oppenheimer rating of Aptiv (NYSE:APTV) on 2/1/2024 |
AMGN Amgen | $285.07 -0.4% | 2/1/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $350.00 | Low | View details for Oppenheimer rating of Amgen (NASDAQ:AMGN) on 2/1/2024 |
ROK Rockwell Automation | $289.88 -0.5% | 2/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $324.00 -> $300.00 | Low | View details for Oppenheimer rating of Rockwell Automation (NYSE:ROK) on 2/1/2024 |
BIIB Biogen | $215.34 -0.5% | 1/30/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $295.00 | Low | View details for Oppenheimer rating of Biogen (NASDAQ:BIIB) on 1/30/2024 |
C Citigroup | $63.20 +0.7% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $93.00 -> $95.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 1/30/2024 |
GS The Goldman Sachs Group | $416.63 +0.3% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $491.00 -> $506.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 1/30/2024 |
JPM JPMorgan Chase & Co. | $200.13 +0.3% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $232.00 -> $238.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 1/30/2024 |
MS Morgan Stanley | $94.19 +0.7% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $106.00 -> $109.00 | Low | View details for Oppenheimer rating of Morgan Stanley (NYSE:MS) on 1/30/2024 |
RMD ResMed | $198.27 +1.0% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $205.00 | Low | View details for Oppenheimer rating of ResMed (NYSE:RMD) on 1/30/2024 |
USB U.S. Bancorp | $44.81 +1.8% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $59.00 -> $61.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 1/30/2024 |
APLS Apellis Pharmaceuticals | $58.55 +0.1% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $75.00 -> $79.00 | Low | View details for Oppenheimer rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 1/30/2024 |
BAC Bank of America | $37.85 +0.1% | 1/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $49.00 -> $50.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 1/30/2024 |
PNST Pinstripes | $3.27 -1.2% | 1/30/2024 | Initiated by | Oppenheimer | - | Outperform | $6.00 | Low | View details for Oppenheimer rating of Pinstripes (NYSE:PNST) on 1/30/2024 |
ST Sensata Technologies | $36.53 +0.3% | 1/30/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $50.00 | Low | View details for Oppenheimer rating of Sensata Technologies (NYSE:ST) on 1/30/2024 |
FIVE Five Below | $182.44 -0.8% | 1/30/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | $235.00 -> $200.00 | Low | View details for Oppenheimer rating of Five Below (NASDAQ:FIVE) on 1/30/2024 |
AXP American Express | $227.58 -0.1% | 1/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $208.00 -> $219.00 | Low | View details for Oppenheimer rating of American Express (NYSE:AXP) on 1/29/2024 |
CRBP Corbus Pharmaceuticals | $39.44 +10.9% | 1/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $51.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 1/29/2024 |
INTU Intuit | $648.73 0.0% | 1/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $610.00 -> $678.00 | Low | View details for Oppenheimer rating of Intuit (NASDAQ:INTU) on 1/29/2024 |
RXST RxSight | $50.93 +0.5% | 1/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $54.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 1/29/2024 |
BFH Bread Financial | $37.01 -1.6% | 1/26/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $52.00 | Low | View details for Oppenheimer rating of Bread Financial (NYSE:BFH) on 1/26/2024 |
COIN Coinbase Global | $266.86 +4.0% | 1/26/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $160.00 | Low | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 1/26/2024 |